Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes
Modern Pathology, Published online: 03 May 2022; doi:10.1038/s41379-022-01074-yImmunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes
Source: Modern Pathology - Category: Pathology Authors: Ali Sakhdari Caleb Class Guillermo Montalban-Bravo Koji Sasaki Carlos E. Bueso-Ramos Keyur P. Patel Mark J. Routbort Sanam Loghavi Chi Young Ok Andres Quesada Joseph D. Khoury Sergej N. Konoplev Hagop P. Kantarjian Guillermo Garcia-Manero L. Jeffrey Medei Source Type: research
More News: Myelodysplastic Syndrome | Pathology